Glomerulonephritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Alerts
• Clinical Trials

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
Conditions:   C3G;   IC-MPGN;   C3 Glomerulopathy;   C3 Glomerulonephritis;   Complement 3 Glomerulopathy;   Complement 3 Glomerulopathy (C3G);   Complement 3 Glomerulonephritis;   Dense Deposit Disease;   DDD;   Membranoproliferative Glomerulonephritis;   Membranoproliferative Glomerul onephritis (MPGN);   Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Interventions:   Drug: Pegcetacoplan;   Other: Placebo Sponsor:   Apellis Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2021 Category: Research Source Type: clinical trials